Savant Capital LLC Trims Holdings in The Clorox Company $CLX

Savant Capital LLC trimmed its stake in The Clorox Company (NYSE:CLX) by 65.7% during the fourth quarter, Holdings Channel.com reports. The fund owned 3,330 shares of the company’s stock after selling 6,368 shares during the period. Savant Capital LLC’s holdings in Clorox were worth $336,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in CLX. Center for Financial Planning Inc. purchased a new stake in shares of Clorox in the 3rd quarter valued at approximately $25,000. Vermillion & White Wealth Management Group LLC purchased a new stake in shares of Clorox in the 3rd quarter valued at approximately $25,000. Darwin Wealth Management LLC purchased a new stake in shares of Clorox in the 2nd quarter valued at approximately $29,000. Vision Financial Markets LLC raised its stake in shares of Clorox by 166.7% in the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock valued at $32,000 after acquiring an additional 200 shares during the period. Finally, Ameriflex Group Inc. raised its stake in shares of Clorox by 1,436.8% in the 3rd quarter. Ameriflex Group Inc. now owns 292 shares of the company’s stock valued at $36,000 after acquiring an additional 273 shares during the period. 78.53% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on CLX shares. Wells Fargo & Company dropped their price objective on shares of Clorox from $100.00 to $95.00 and set an “equal weight” rating on the stock in a research report on Monday, May 18th. TD Cowen increased their price objective on shares of Clorox from $98.00 to $111.00 and gave the company a “hold” rating in a research report on Tuesday, March 31st. Wall Street Zen raised shares of Clorox from a “sell” rating to a “hold” rating in a research report on Saturday, February 7th. BNP Paribas Exane dropped their target price on shares of Clorox from $128.00 to $97.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 12th. Finally, Evercore reaffirmed an “underperform” rating and issued a $110.00 target price on shares of Clorox in a research report on Friday, May 1st. One equities research analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Reduce” and an average price target of $103.40.

Clorox Trading Up 4.9%

NYSE CLX opened at $94.07 on Friday. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The firm’s fifty day moving average price is $96.95 and its 200 day moving average price is $105.31. The company has a market capitalization of $11.37 billion, a price-to-earnings ratio of 15.27, a price-to-earnings-growth ratio of 0.46 and a beta of 0.56. The Clorox Company has a 12 month low of $84.70 and a 12 month high of $132.03.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. The firm had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company’s revenue was up .1% on a year-over-year basis. During the same period last year, the firm posted $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, sell-side analysts expect that The Clorox Company will post 5.61 earnings per share for the current fiscal year.

Insider Activity at Clorox

In related news, Director Pierre R. Breber bought 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 5th. The shares were purchased at an average cost of $85.82 per share, with a total value of $429,100.00. Following the transaction, the director directly owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This represents a 38.46% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.63% of the stock is owned by company insiders.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.